We are pleased and honored to introduce Bia Labate, PhD, to the Soltara advisory team as Science and Culture Coordinator.
08:43 min
CLEAR ALL
Drugs like LSD and MDMA are generating new interest among doctors for use in psychotherapy.
1
Leading psychopharmacologist Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
2
Psychedelics have an ancient and more recent history of medicinal-use. Administered in a supportive environment, with preparatory and integrative psychological care, psychedelic medicines are now being used to facilitate emotional breakthrough and renewed perspective.
REBUS and the Anarchic Brain: A Unified Model of the Brain Action of Psychedelics Robin Carhart-Harris moved to Imperial College London in 2008 after obtaining a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University.
Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.
Robert Jesse will offer a view, spanning the decade from the birth of Horizons to the present day, of the significant developments that have occurred in several areas of our field. Surely they amount to a re-emergence of psychedelics. People speak of a renaissance.
Robert Jesse is the organiser of the Council on Spiritual Practices, which aims to shift modernity's awareness and practices with respect to primary religious experience.
Natalie Ginsberg, MSW, discusses ayahuasca and the healing potential of psychedelics for intergenerational trauma in the Palestinian-Israeli conflict.
"We met, married and formed a research team about twenty five years ago. This called upon a background of psychedelic drug invention and exploration of the previous twenty years, but it added a new dimension to this area of exploration.
3